Read + Share
Liu CL, Hsu YC, Kuo CY, Jhuang JY, et al. CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the
integrin/FAK/AKT pathway. Endocrinology 2022 Oct 14. pii: 6761323. doi: 10.1210.
PMID: 36240291
|
 |
|
Liu CL, Hsu YC, Kuo CY, Jhuang JY, et al. CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the
integrin/FAK/AKT pathway. Endocrinology 2022 Oct 14. pii: 6761323. doi: 10.1210.
PMID: 36240291
|
|
|
|